MKI67 and neoplasm: Although the median expression of Ki67 was generally lower in metastatic lesions (45%) than in the matched primary tumour (60%) (Supplementary Figure 1b; E and F), the difference in the expression pattern of both PR and Ki67 between the two groups was not statistically significant (Figure 3C).